Hemicrania continua

Robert W. Charlson, Matthew S. Robbins

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In recent years, hemicrania continua has become a well-recognized primary headache disorder known for its chronicity and resulting disability in a subset of patients with headache. The core clinical features have been well described: unilateral, side-locked headaches that are continuous (although interrupted by frequent severe exacerbations), associated with autonomic symptoms and a response to indomethacin. However, areas of relative controversy remain in its classification and diagnosis. Several relatively large case series have better delineated the associated features of this disorder, including atypical presentations. Recently, neuroimaging research has provided new insights into the underlying pathways involved in the disorder, in particular activation of the contralateral posterior hypothalamus and the ipsilateral dorsal rostral pons. Despite its well-known response to indomethacin, many patients still endure long delays in the appropriate diagnosis and treatment. There remains a need for new treatments given the morbidity associated with long-term indomethacin use.

Original languageEnglish (US)
JournalCurrent Neurology and Neuroscience Reports
Volume14
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Indomethacin
Headache
Primary Headache Disorders
Posterior Hypothalamus
Pons
Neuroimaging
Morbidity
Therapeutics
Research

Keywords

  • Hemicrania continua
  • Indomethacin-responsive headache
  • Review
  • Trigeminal autonomic cephalalgia
  • Unilateral headache

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Hemicrania continua. / Charlson, Robert W.; Robbins, Matthew S.

In: Current Neurology and Neuroscience Reports, Vol. 14, No. 3, 2014.

Research output: Contribution to journalArticle

Charlson, Robert W. ; Robbins, Matthew S. / Hemicrania continua. In: Current Neurology and Neuroscience Reports. 2014 ; Vol. 14, No. 3.
@article{14e3553c6385431380fe52e4356ca048,
title = "Hemicrania continua",
abstract = "In recent years, hemicrania continua has become a well-recognized primary headache disorder known for its chronicity and resulting disability in a subset of patients with headache. The core clinical features have been well described: unilateral, side-locked headaches that are continuous (although interrupted by frequent severe exacerbations), associated with autonomic symptoms and a response to indomethacin. However, areas of relative controversy remain in its classification and diagnosis. Several relatively large case series have better delineated the associated features of this disorder, including atypical presentations. Recently, neuroimaging research has provided new insights into the underlying pathways involved in the disorder, in particular activation of the contralateral posterior hypothalamus and the ipsilateral dorsal rostral pons. Despite its well-known response to indomethacin, many patients still endure long delays in the appropriate diagnosis and treatment. There remains a need for new treatments given the morbidity associated with long-term indomethacin use.",
keywords = "Hemicrania continua, Indomethacin-responsive headache, Review, Trigeminal autonomic cephalalgia, Unilateral headache",
author = "Charlson, {Robert W.} and Robbins, {Matthew S.}",
year = "2014",
doi = "10.1007/s11910-013-0436-2",
language = "English (US)",
volume = "14",
journal = "Current Neurology and Neuroscience Reports",
issn = "1528-4042",
publisher = "Current Medicine Group",
number = "3",

}

TY - JOUR

T1 - Hemicrania continua

AU - Charlson, Robert W.

AU - Robbins, Matthew S.

PY - 2014

Y1 - 2014

N2 - In recent years, hemicrania continua has become a well-recognized primary headache disorder known for its chronicity and resulting disability in a subset of patients with headache. The core clinical features have been well described: unilateral, side-locked headaches that are continuous (although interrupted by frequent severe exacerbations), associated with autonomic symptoms and a response to indomethacin. However, areas of relative controversy remain in its classification and diagnosis. Several relatively large case series have better delineated the associated features of this disorder, including atypical presentations. Recently, neuroimaging research has provided new insights into the underlying pathways involved in the disorder, in particular activation of the contralateral posterior hypothalamus and the ipsilateral dorsal rostral pons. Despite its well-known response to indomethacin, many patients still endure long delays in the appropriate diagnosis and treatment. There remains a need for new treatments given the morbidity associated with long-term indomethacin use.

AB - In recent years, hemicrania continua has become a well-recognized primary headache disorder known for its chronicity and resulting disability in a subset of patients with headache. The core clinical features have been well described: unilateral, side-locked headaches that are continuous (although interrupted by frequent severe exacerbations), associated with autonomic symptoms and a response to indomethacin. However, areas of relative controversy remain in its classification and diagnosis. Several relatively large case series have better delineated the associated features of this disorder, including atypical presentations. Recently, neuroimaging research has provided new insights into the underlying pathways involved in the disorder, in particular activation of the contralateral posterior hypothalamus and the ipsilateral dorsal rostral pons. Despite its well-known response to indomethacin, many patients still endure long delays in the appropriate diagnosis and treatment. There remains a need for new treatments given the morbidity associated with long-term indomethacin use.

KW - Hemicrania continua

KW - Indomethacin-responsive headache

KW - Review

KW - Trigeminal autonomic cephalalgia

KW - Unilateral headache

UR - http://www.scopus.com/inward/record.url?scp=84892576035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892576035&partnerID=8YFLogxK

U2 - 10.1007/s11910-013-0436-2

DO - 10.1007/s11910-013-0436-2

M3 - Article

C2 - 24452694

AN - SCOPUS:84892576035

VL - 14

JO - Current Neurology and Neuroscience Reports

JF - Current Neurology and Neuroscience Reports

SN - 1528-4042

IS - 3

ER -